Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Onstad

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Transplantation and Cellular Therapy|September 3, 2022
Late Effects of Severe Acute Graft-versus-Host Disease on Quality of Life, Medical Comorbidities, and SurvivalNahid Rashid, Elizabeth F Krakow, Albert C Yeh, et al.
Haematologica|May 26, 2022
Durable discontinuation of systemic therapy in patients affected by chronic graft-<i>versus</i>-host diseaseGeorge L Chen, Lynn Onstad, Paul J Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2019
Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of LifeGeorge E Georges, Merav Bar, Lynn Onstad, et al.
Haematologica|June 3, 2018
Patient-reported outcomes and health status associated with chronic graft-<i>versus</i>-host diseaseStephanie J Lee, Lynn Onstad, Eric J Chow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2014
Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohortSheetal Hardikar, Lynn Onstad, Xiaoling Song, et al.
International Journal of Epidemiology|October 20, 2019
Female breast cancer risk in Bryansk Oblast, Russia, following prolonged low dose rate exposure to radiation from the Chernobyl power station accidentNikolai Rivkind, Valeriy Stepanenko, Irina Belukha, et al.
JAMA Dermatology|March 8, 2023
Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host DiseaseEmily Baumrin, Laura X Baker, Michael Byrne, et al.
Transplantation and Cellular Therapy|June 19, 2022
Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation SurvivorsTanya Lehky, Iago Pinal Fernandez, Elizabeth F Krakow, et al.
Transplantation and Cellular Therapy|September 4, 2022
Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on ImmunosuppressionShivaprasad Manjappa, Huy Q Phi, Lik Wee Lee, et al.
American Journal of Hematology|July 1, 2026
Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" TrialBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Transplantation and Cellular Therapy|September 3, 2022
Late Effects of Severe Acute Graft-versus-Host Disease on Quality of Life, Medical Comorbidities, and SurvivalNahid Rashid, Elizabeth F Krakow, Albert C Yeh, et al.
Haematologica|May 26, 2022
Durable discontinuation of systemic therapy in patients affected by chronic graft-<i>versus</i>-host diseaseGeorge L Chen, Lynn Onstad, Paul J Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2019
Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of LifeGeorge E Georges, Merav Bar, Lynn Onstad, et al.
Haematologica|June 3, 2018
Patient-reported outcomes and health status associated with chronic graft-<i>versus</i>-host diseaseStephanie J Lee, Lynn Onstad, Eric J Chow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2014
Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohortSheetal Hardikar, Lynn Onstad, Xiaoling Song, et al.
International Journal of Epidemiology|October 20, 2019
Female breast cancer risk in Bryansk Oblast, Russia, following prolonged low dose rate exposure to radiation from the Chernobyl power station accidentNikolai Rivkind, Valeriy Stepanenko, Irina Belukha, et al.
JAMA Dermatology|March 8, 2023
Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host DiseaseEmily Baumrin, Laura X Baker, Michael Byrne, et al.
Transplantation and Cellular Therapy|June 19, 2022
Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation SurvivorsTanya Lehky, Iago Pinal Fernandez, Elizabeth F Krakow, et al.
Transplantation and Cellular Therapy|September 4, 2022
Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on ImmunosuppressionShivaprasad Manjappa, Huy Q Phi, Lik Wee Lee, et al.
American Journal of Hematology|July 1, 2026
Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" TrialBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.
Pageof 7